NIDA Policy Update for Career Development Awards (K Awards)

Notice Number: NOT-DA-05-001 (This notice has been superseded by NOT-DA-05-005)

Key Dates
Release Date: October 28, 2004

Issued by
National Institute on Drug Abuse (NIDA), (


This Notice regarding the National Institutes of Health (NIH) Career Development Program Announcements (K Awards) is intended to provide additional information for potential applicants on the unique aspects of National Institute on Drug Abuse (NIDA) career development programs. This supersedes the one dated August 5, 1999. The NIH program announcements addressed in this Notice are the following:

PA-00-019: Mentored Research Scientist Development Award (K0l)
PA-00-020: Independent Scientist Award (K02)
PA-00-021: Senior Scientist Award (K05)
PA-00-003: Mentored Clinical Scientist Development Award (K08)
PAR-02-076: Mentored Clinical Scientists Development Program Award (K12)
PA-00-004: Mentored Patient-Oriented Research Career Development Award (K23)
PA-04-107: Midcareer Investigator Award in Patient-Oriented Research (K24)
PA-02-127: Mentored Quantitative Research Career Development Award (K25)

The guidelines and procedures outlined in NIH program announcements must be followed closely when an application is being prepared for submission to the NIDA, Particular attention should be paid to the purpose of each award mechanism, its eligibility requirements, and its review considerations.

Note: This policy is effective and applicable only to new, competing applications submitted after February 1, 2005.

Additional Information for NIDA Applicants

The RESEARCH OBJECTIVES section of each program announcement should be followed carefully during the preparation of an application. Note especially that differences exist among various NIH Institutes regarding allowable costs. The unique aspects of NIDA allowable costs, specifically in the categories of salary (all Ks) and research development support (K01, K08, K23, K25), are listed below.

Salary (K01, K02, K05, K08, K12, K23, K24, K25)

This policy applies to all new (type 1), competitive renewal (type 2), and non-competitive renewal (type 5) applications. The NIDA contribution to the principal investigator's salary is geared to institutional base salary as follows:

Institutional Base Salary
NIDA Contribution
Up to $48,000 100% of institutional base salary
$48,001 to $64,000 $48,000
$64,001 and over 75% of institutional base salary, up to cap of $90,000

Research Development Support (K01, K08, K23, K24, K25)

NIDA allows for funds up to $50,000 per year for research-related costs as outlined in each program announcement--examples include supplies, equipment, technical personnel, travel, and statistical services. [Note: This new amount is effective only for new, competing applications received after February 1, 2005).

Research Support (K02, K05)

For the K02 and K05 awards, NIDA allows for funds up to $25,000 per year for those applications from individuals who are engaged in predominantly theoretical work, such as modeling or computer simulation, as outlined in each program announcement.


K01, K08, K23, K25 Awards:

Support for the K01, K08, K23, K25 awards are limited to one term of 3 to 5 years and are further restricted to one mentored career award per individual.

K02 and K24:

The Independent Scientist Award (K02) and Midcareer Investigator Award in Patient-Oriented Research (K24) are renewable one time only.


Consultation with NIDA staff is encouraged especially during the planning phase of the application. Below are the names of the NIDA staff who can provide further information:

NIDA Institute Coordinators

Susan Weiss, Ph.D.
Coordinator, NIDA Research Training Committee
Office of Science Policy and Communications
(301) 443-6071
(301) 480-2485 ( fax)

Suman A. Rao, Ph.D.
Deputy Coordinator, NIDA Research Training Committee
Office of Science Policy and Communications
(301) 443-6071
(301) 480-2485 (fax)

For Programmatic Issues:

Division of Basic Neurosciences and Behavioral Research

Charles W. Sharp, Ph.D.
(301) 443-1887
(301) 594-6043 (fax)

Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Jamie Biswas, Ph.D.
(301) 443-8494
(301) 443-9649 (fax)

Division of Epidemiology, Services, and Prevention Research

William Bukoski, Ph.D.
(301) 402-1526
(301) 402-2636 (fax)

Division of Clinical Neuroscience, Development, and Behavioral Treatment

Dorynne Czechowicz, Ph.D.
(301) 443-2237
(301) 443-6814 (fax)

For Review Issues:

Office of Extramural Affairs

Mark Swieter, Ph.D.
(301) 435-1389
(301) 443-0538 (fax)

Eliane Lazar-Wesley, Ph.D.
(301) 451-4530
(301) 443-0538 (fax)

For Grants Management Issues:

Gary Fleming, J.D., M.A.
Chief, Grants Management Officer
(301) 443-6710
(301) 594-6849 (fax)

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.